DocCheck AG

XTRA:AJ91 Stok Raporu

Piyasa değeri: €41.4m

DocCheck Yönetim

Yönetim kriter kontrolleri 4/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Frank Antwerpes

İcra Kurulu Başkanı

€244.7k

Toplam tazminat

CEO maaş yüzdesi75.5%
CEO görev süresino data
CEO sahipliği55.7%
Yönetim ortalama görev süresi5.3yrs
Yönetim Kurulu ortalama görev süresi25.8yrs

Son yönetim güncellemeleri

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Recent updates

DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business

Nov 19
DocCheck's (ETR:AJ91) Returns On Capital Not Reflecting Well On The Business

We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

Apr 19
We Think You Can Look Beyond DocCheck's (ETR:AJ91) Lackluster Earnings

DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Aug 04
DocCheck (ETR:AJ91) Has Some Way To Go To Become A Multi-Bagger

Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

May 20
Estimating The Fair Value Of DocCheck AG (ETR:AJ91)

The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Nov 06
The Trend Of High Returns At DocCheck (ETR:AJ91) Has Us Very Interested

Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

Mar 03
Returns On Capital Are A Standout For DocCheck (ETR:AJ91)

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Jan 18
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Aug 26
Do DocCheck's (ETR:AJ91) Earnings Warrant Your Attention?

Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

May 02
Should DocCheck AG (ETR:AJ91) Be Part Of Your Dividend Portfolio?

Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Apr 18
Investors Shouldn't Overlook DocCheck's (ETR:AJ91) Impressive Returns On Capital

Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Mar 23
Should You Be Adding DocCheck (ETR:AJ91) To Your Watchlist Today?

Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 04
Is DocCheck AG's (ETR:AJ91) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Feb 14
Did You Participate In Any Of DocCheck's (ETR:AJ91) Incredible 419% Return?

Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Jan 27
Could The DocCheck AG (ETR:AJ91) Ownership Structure Tell Us Something Useful?

Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

Jan 10
Under The Bonnet, DocCheck's (ETR:AJ91) Returns Look Impressive

If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

Dec 22
If You Like EPS Growth Then Check Out DocCheck (ETR:AJ91) Before It's Too Late

What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

Dec 07
What Can We Conclude About DocCheck's (ETR:AJ91) CEO Pay?

DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 22
DocCheck AG's (ETR:AJ91) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

CEO Tazminat Analizi

Frank Antwerpes'un ücretlendirmesi DocCheck'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

€2m

Mar 31 2024n/an/a

€2m

Dec 31 2023€245k€185k

€2m

Sep 30 2023n/an/a

€4m

Jun 30 2023n/an/a

€6m

Mar 31 2023n/an/a

€6m

Dec 31 2022€250k€190k

€6m

Sep 30 2022n/an/a

€7m

Jun 30 2022n/an/a

€7m

Mar 31 2022n/an/a

€9m

Dec 31 2021€250k€190k

€11m

Sep 30 2021n/an/a

€12m

Jun 30 2021n/an/a

€13m

Mar 31 2021n/an/a

€11m

Dec 31 2020€211k€151k

€9m

Sep 30 2020n/an/a

€7m

Jun 30 2020n/an/a

€4m

Mar 31 2020n/an/a

€4m

Dec 31 2019€245k€185k

€3m

Sep 30 2019n/an/a

€3m

Jun 30 2019n/an/a

€3m

Mar 31 2019n/an/a

€3m

Dec 31 2018€244k€184k

€2m

Sep 30 2018n/an/a

€2m

Jun 30 2018n/an/a

€2m

Mar 31 2018n/an/a

€2m

Dec 31 2017€237k€177k

€2m

Tazminat ve Piyasa: Frank 'nin toplam tazminatı ($USD 256.39K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 472.15K ).

Tazminat ve Kazançlar: Frank 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Frank Antwerpes

no data

Görev süresi

€244,721

Tazminat

Dr. Frank Nicolas Antwerpes serves as the Chief Executive Officer at DocCheck Guano AG. He served as the Chief Executive Officer of DocCheck Medizinbedarf und Logistik GmbH. Dr. Antwerpes serves as Preside...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Frank Antwerpes
President of the Management Board & CEOno data€244.72k55.71%
€ 23.0m
Philip Stadtmann
CFO & Member of Management Board5.3yrs€232.41kVeri yok
Thilo Kolzer
COO & Member of Management Board5.3yrs€234.81kVeri yok
Jens Knoop
CTO & Member of Management Board5.3yrs€195.80kVeri yok

5.3yrs

Ortalama Görev Süresi

Deneyimli Yönetim: AJ91 'un yönetim ekibi deneyimli ve deneyimlidir ( 5.3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Joachim Pietzko
Chairman of the Supervisory Board25.8yrs€19.20kVeri yok
Winfried Leimeister
Deputy Chairwoman of the Supervisory Board25.8yrs€9.60kVeri yok
Karin Immenroth
Chief Data & Analytics Officer and Member of Supervisory Board2.5yrs€9.60kVeri yok

25.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: AJ91 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 25.8 yıldır).